Lord, Abbett & Co. LLC Scholar Rock Holding Corp Transaction History

Lord, Abbett & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$26.34 - $46.62 $20.6 Million - $36.4 Million	-781,111 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$45.96 - $68.02 $26.8 Million - $39.6 Million	582,126 Added 292.55%	781,111 $39.6 Million
Q4 2020 Feb 09, 2021	BUY	$13.72 - $51.57 $2.73 Million - $10.3 Million	198,985 New	198,985 $9.66 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.